Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
Halo Collective Cash from Investing (Quarterly): 0.4945M for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 0.4945M |
March 31, 2023 | 2.936M |
December 31, 2022 | -1.326M |
September 30, 2022 | -0.0298M |
June 30, 2022 | 2.326M |
March 31, 2022 | -0.7165M |
December 31, 2021 | -1.103M |
September 30, 2021 | 0.7629M |
June 30, 2021 | -0.4696M |
March 31, 2021 | 1.019M |
December 31, 2020 | -2.456M |
September 30, 2020 | -0.0883M |
June 30, 2020 | -0.1828M |
March 31, 2020 | 0.00 |
December 31, 2019 | -0.7521M |
September 30, 2019 | 0.1703M |
June 30, 2019 | -0.9259M |
March 31, 2019 | -0.3471M |
June 30, 2018 | -0.0111M |
March 31, 2018 | -0.0165M |
December 31, 2017 | -0.0086M |
September 30, 2017 | 0.6384M |
June 30, 2017 | 0.0346M |
March 31, 2017 | 0.0439M |
December 31, 2016 | 0.0406M |
Date | Value |
---|---|
September 30, 2016 | 0.1029M |
June 30, 2016 | 0.0472M |
March 31, 2016 | 0.0186M |
December 31, 2015 | 0.00 |
September 30, 2015 | |
June 30, 2015 | -0.188M |
March 31, 2015 | 0.0499M |
December 31, 2014 | 0.0889M |
September 30, 2014 | 0.4884M |
June 30, 2014 | 0.3668M |
March 31, 2014 | -1.088M |
December 31, 2013 | -0.0031M |
September 30, 2013 | 0.6873M |
June 30, 2013 | 3.028M |
March 31, 2013 | -0.1196M |
December 31, 2012 | -1.008M |
September 30, 2012 | -1.965M |
June 30, 2012 | -2.747M |
March 31, 2012 | -3.958M |
December 31, 2011 | -3.983M |
September 30, 2011 | -4.119M |
June 30, 2011 | -2.941M |
March 31, 2011 | -1.372M |
December 31, 2010 | -0.8381M |
September 30, 2010 | -0.6489M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.456M
Minimum
Dec 2020
2.936M
Maximum
Mar 2023
-0.0201M
Average
-0.0883M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
CEN Biotech Inc | -0.0496M |
Acasti Pharma Inc | -6.554M |
Aurinia Pharmaceuticals Inc | -6.257M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -0.057M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.4658M |
Cash from Financing (Quarterly) | -0.4607M |
Free Cash Flow | -4.181M |
Free Cash Flow Per Share (Quarterly) | -0.0031 |
Free Cash Flow to Equity (Quarterly) | -0.8621M |
Free Cash Flow to Firm (Quarterly) | -0.2378M |